NEPAFENAC (Nevanac®)

Clinical Indication

Pain and inflammation post cataract surgery and Cystoid Macular Oedema in Uveitic Patients

Date of classification

June 2025

Red

Medicines which should be prescribed only in a specialist setting usually within a secondary or tertiary care service. NB: Some highly specialised RED medicines e.g. injectable treatments for cancer are not included on the LLR APC website list.